Clinical management of patients receiving cell-based immunoregulatory therapy

Hutchinson, James A. and Ahrens, Norbert and Riquelme, Paloma and Walter, Lisa and Gruber, Michael and Boeger, Carsten A. and Farkas, Stefan and Scherer, Marcus N. and Broichhausen, Christiane and Bein, Thomas and Schlitt, Hans-J. and Faendrich, Fred and Banas, Bernhard and Geissler, Edward K. (2014) Clinical management of patients receiving cell-based immunoregulatory therapy. TRANSFUSION, 54 (9). pp. 2336-2343. ISSN 0041-1132, 1537-2995

Full text not available from this repository. (Request a copy)

Abstract

Administering immunoregulatory cells as medicinal agents is a revolutionary approach to the treatment of immunologically mediated diseases. Isolating, propagating, and modifying cells before applying them to patients allows complementation of specific cellular functions, which opens astonishing new possibilities for gain-of-function antigen-specific treatments in autoimmunity, chronic inflammatory disorders, and transplantation. This critical review presents a systematic assessment of the potential clinical risks posed by cell-based immunotherapy, focusing on treatment of renal transplant recipients with regulatory macrophages as a concrete example.

Item Type: Article
Uncontrolled Keywords: HUMAN REGULATORY MACROPHAGES; ACCEPTANCE-INDUCING-CELLS; T-CELLS; BLOOD-TRANSFUSION; TRANSPLANT RECIPIENTS; RENAL-TRANSPLANTATION; ALLOGRAFT SURVIVAL; FOXP3 EXPRESSION; PULMONARY; LUNG;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Anästhesiologie
Medicine > Lehrstuhl für Chirurgie
Medicine > Abteilung für Nephrologie
Medicine > Lehrstuhl für Klinische Chemie und Laboratoriumsmedizin
Depositing User: Petra Gürster
Date Deposited: 04 Aug 2020 09:57
Last Modified: 04 Aug 2020 09:57
URI: https://pred.uni-regensburg.de/id/eprint/9644

Actions (login required)

View Item View Item